 |
|
Changes in Serum Osteocalcin are Not Associated with Changes in Glucose or Insulin for Osteoporotic Patients Treated with Bisphosphonate
Seong-hun Hong, Ja-won Koo, Jin Kyung Hwang, You-Cheol Hwang, In-Kyung Jeong, Kyu Jeung Ahn, Ho-Yeon Chung, Deog-Yoon Kim
J Bone Metab. 2013;20(1):37-41. Published online 2013 May 13 DOI: https://doi.org/10.11005/jbm.2013.20.1.37
|
|
Citations to this article as recorded by
 Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis
Po-Wei Chen, Hsiao-Yuan Su, Yu-Kang Tu, Chih-Hsing Wu, Jih-I Yeh, Li-Yu Chen, Carol Chiung-Hui Peng, Ching-Hui Loh, Huei-Kai Huang, Shu-Man Lin
Osteoporosis International.2023; 34(2): 387. CrossRef Bone circuitry and interorgan skeletal crosstalk
Mone Zaidi, Se-Min Kim, Mehr Mathew, Funda Korkmaz, Farhath Sultana, Sari Miyashita, Anisa Azatovna Gumerova, Tal Frolinger, Ofer Moldavski, Orly Barak, Anusha Pallapati, Satish Rojekar, John Caminis, Yelena Ginzburg, Vitaly Ryu, Terry F Davies, Daria Liz
eLife.2023;[Epub] CrossRef Undercarboxylated osteocalcin and ibandronate combination ameliorates hindlimb immobilization‐induced muscle wasting
Xuzhu Lin, Cassandra Smith, Alba Moreno‐Asso, Navabeh Zarekookandeh, Tara C. Brennan‐Speranza, Gustavo Duque, Alan Hayes, Itamar Levinger
The Journal of Physiology.2023; 601(10): 1851. CrossRef Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial
Jinyoung Kim, Kyoung Min Kim, Soo Lim, Moo-Il Kang, Ki-Hyun Baek, Yong-Ki Min
BMC Endocrine Disorders.2022;[Epub] CrossRef General Commentary: Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study
Burkhard Muche
Frontiers in Endocrinology.2022;[Epub] CrossRef Effects of Bisphosphonate on Osteocyte Proliferation and Bone Formation in Patients with Diabetic Osteoporosis
Beifang Weng, Chunhua Chen, Min Tang
Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?
Athanasios Anastasilakis, Elena Tsourdi, Gaia Tabacco, Anda Naciu, Nicola Napoli, Fabio Vescini, Andrea Palermo
Journal of Clinical Medicine.2021; 10(5): 996. CrossRef Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trial
Ada S. Cheung, Rudolf Hoermann, Jasmine Zhu, Daryl Lim Joon, Jeffrey D. Zajac, Mathis Grossmann
Therapeutic Advances in Endocrinology and Metabolism.2021; 12: 204201882110121. CrossRef Are Bisphosphonates Associated with Adverse Metabolic and Cognitive Effects? A Study in Intact Rats and Rats Fed High-Fat High-Fructose Diet
Silvia Gancheva, Maria Zhelyazkova-Savova
Calcified Tissue International.2020; 107(1): 41. CrossRef Teriparatide Improves Bone and Lipid Metabolism in a Male Rat Model of Type 2 Diabetes Mellitus
Sachiko Nomura, Akihiro Kitami, Ryoko Takao-Kawabata, Aya Takakura, Momoko Nakatsugawa, Ryohei Kono, Akihiro Maeno, Akihiko Tokuda, Yukihiro Isogai, Toshinori Ishizuya, Hirotoshi Utsunomiya, Misa Nakamura
Endocrinology.2019; 160(10): 2339. CrossRef Osteocalcin and its endocrine functions
Akiko Mizokami, Tomoyo Kawakubo-Yasukochi, Masato Hirata
Biochemical Pharmacology.2017; 132: 1. CrossRef The systemic nature of CKD
Carmine Zoccali, Raymond Vanholder, Ziad A. Massy, Alberto Ortiz, Pantelis Sarafidis, Friedo W. Dekker, Danilo Fliser, Denis Fouque, Gunnar H. Heine, Kitty J. Jager, Mehmet Kanbay, Francesca Mallamaci, Gianfranco Parati, Patrick Rossignol, Andrzej Wiecek,
Nature Reviews Nephrology.2017; 13(6): 344. CrossRef An overview of osteocalcin progress
Jinqiao Li, Hongyu Zhang, Chao Yang, Yinghui Li, Zhongquan Dai
Journal of Bone and Mineral Metabolism.2016; 34(4): 367. CrossRef Effect of 3-keto-1,5-bisphosphonates on obese-liver’s rats
Karima Lahbib, Soufiane Touil
Biomedicine & Pharmacotherapy.2016; 83: 186. CrossRef Association of Serum Osteocalcin with Insulin Resistance and Coronary Atherosclerosis
Jee-Hyun Kang
Journal of Bone Metabolism.2016; 23(4): 183. CrossRef DLK1 Regulates Whole-Body Glucose Metabolism: A Negative Feedback Regulation of the Osteocalcin-Insulin Loop
Basem M. Abdallah, Nicholas Ditzel, Jorge Laborda, Gerard Karsenty, Moustapha Kassem
Diabetes.2015; 64(9): 3069. CrossRef Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes
Renyuan Li, Wen Xu, Sihui Luo, Haixia Xu, Guoyu Tong, Longyi Zeng, Dalong Zhu, Jianping Weng
Acta Diabetologica.2015; 52(6): 1083. CrossRef Effect of intermittent PTH treatment on plasma glucose in osteoporosis: A randomized trial
Patrizia D'Amelio, Francesca Sassi, Ilaria Buondonno, Elena Spertino, Cristina Tamone, Simonetta Piano, Daniela Zugna, Lorenzo Richiardi, Giovanni Carlo Isaia
Bone.2015; 76: 177. CrossRef Regulation of energy metabolism by the skeleton: Osteocalcin and beyond
Mathieu Ferron, Julie Lacombe
Archives of Biochemistry and Biophysics.2014; 561: 137. CrossRef An NMR Metabolomic Study on the Effect of Alendronate in Ovariectomized Mice
Shin-Yu Chen, Hui-Tzu Yu, Ju-Po Kao, Chung-Chun Yang, Shen-Shih Chiang, Darya O. Mishchuk, Jeng-Leun Mau, Carolyn M. Slupsky, Daniel Monleon
PLoS ONE.2014; 9(9): e106559. CrossRef Bone as an Endocrine Organ Relevant to Diabetes
Sarah L. Booth, Amanda J. Centi, Caren Gundberg
Current Diabetes Reports.2014;[Epub] CrossRef
|